Insulin Glargine for Dysglycemia Protects Against Cognitive Impairment
Insulin glargine for dysglycemia was associated with a reduced cognitive impairment risk after a median follow-up of 6.2 years.
Stay updated with breaking news from Initial Glargine Intervention. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Insulin glargine for dysglycemia was associated with a reduced cognitive impairment risk after a median follow-up of 6.2 years.
Insulin glargine for dysglycemia was associated with a reduced cognitive impairment risk after a median follow-up of 6.2 years.
Insulin glargine for dysglycemia was associated with a reduced cognitive impairment risk after a median follow-up of 6.2 years.
Researchers develop a healthy diet score linked to health outcomes with global applicability using the Prospective Urban Rural Epidemiology study data.
At EASD, two experts debate the future of insulin therapy for type 2 diabetes.